Intercure Ltd.
INCR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001857030
No open-market purchases or sales by Intercure Ltd. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $764.1K in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Intercure Ltd. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 19 | 22 | +3 |
| Shares | 2.49M | 2.11M | −386.3K (−15.5%) |
| Value | $3.68M | $3.44M | −$242.8K (−6.6%) |
New holders (4)
Institutions that held Intercure Ltd. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Goldman Sachs Group Inc | 1,262,726 | $2.07M | 0.00% |
| Jane Street Group, LLC | 214,253 | $355.1K | 0.00% |
| StoneX Group Inc. | 49,541 | $81.2K | 0.00% |
| PenderFund Capital Management Ltd. | 1,977 | $3.24K | 0.00% |
Sold out (1)
Institutions that held Intercure Ltd. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Ibex Investors LLC | 1,886,274 | $2.77M |